期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 約3.0個(gè)月 約5.2周

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

國(guó)際臨床化學(xué)和實(shí)驗(yàn)室醫(yī)學(xué)聯(lián)合會(huì) (IFCC) 官方期刊

Clinica Chimica Acta 是一本高質(zhì)量期刊，發(fā)表臨床化學(xué)和實(shí)驗(yàn)室醫(yī)學(xué)領(lǐng)域的原創(chuàng)研究通訊，臨床化學(xué)和實(shí)驗(yàn)室醫(yī)學(xué)定義為化學(xué)、生物化學(xué)、免疫化學(xué)、血液學(xué)生化方面、毒理學(xué)和分子生物學(xué)在體液和細(xì)胞中人類(lèi)疾病研究中的診斷應(yīng)用。

該期刊的目標(biāo)是發(fā)表新穎的??信息，從而更好地了解人類(lèi)疾病的生物機(jī)制、預(yù)防、診斷和患者管理。也歡迎具有應(yīng)用臨床特征的報(bào)告。與正常代謝過(guò)程或正常細(xì)胞或體液成分有關(guān)的論文，例如動(dòng)物實(shí)驗(yàn)或臨床研究報(bào)告，只有在與人類(lèi)疾病明確直接相關(guān)時(shí)才會(huì)被考慮。商業(yè)產(chǎn)品的評(píng)估在出版方面具有較低的優(yōu)先級(jí)，除非它們是新穎的或代表了技術(shù)突破。涉及藥物和天然產(chǎn)物影響的研究以及涉及各種疾病的氧化還原狀態(tài)的研究不屬于該期刊的范圍。還將考慮開(kāi)發(fā)和評(píng)估適用于診斷臨床化學(xué)和實(shí)驗(yàn)室醫(yī)學(xué)的新型分析方法，包括即時(shí)檢測(cè)，以及實(shí)驗(yàn)室管理和信息學(xué)主題。專(zhuān)注于新興診斷技術(shù)和（大）數(shù)據(jù)分析程序的研究，包括數(shù)字化、移動(dòng)醫(yī)療和應(yīng)用于實(shí)驗(yàn)室醫(yī)學(xué)的人工智能，也引起了人們的興趣。

《Clinica Chimica Acta》(Acta 化學(xué)診所)編輯部通訊方式為ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢(xún)我們的客服老師。我們專(zhuān)注于期刊咨詢(xún)服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。